MicuRx Pharmaceuticals Company
MicuRx discovers and develops novel antibiotics to prevent and treat drug-resistant bacterial infections.
Estimated Revenue:
$10M to $50M
Funding Status:
Late Stage Venture
Industry:
PharmTech
Number Of Exists:
N/A
Technology:
Small Molecules
Founded Date:
2007
Investor Type:
N/A
Headquarters:
Hayward, California, United States
Employee Number:
11-50
Investment Stage:
N/A